Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

32 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Genetic Variants of VEGFA and FLT4 Are Determinants of Survival in Renal Cell Carcinoma Patients Treated with Sorafenib.
Crona DJ, Skol AD, Leppänen VM, Glubb DM, Etheridge AS, Hilliard E, Peña CE, Peterson YK, Klauber-DeMore N, Alitalo KK, Innocenti F. Crona DJ, et al. Among authors: hilliard e. Cancer Res. 2019 Jan 1;79(1):231-241. doi: 10.1158/0008-5472.CAN-18-1089. Epub 2018 Nov 1. Cancer Res. 2019. PMID: 30385613 Free PMC article. Clinical Trial.
The role of calcineurin/NFAT in SFRP2 induced angiogenesis--a rationale for breast cancer treatment with the calcineurin inhibitor tacrolimus.
Siamakpour-Reihani S, Caster J, Bandhu Nepal D, Courtwright A, Hilliard E, Usary J, Ketelsen D, Darr D, Shen XJ, Patterson C, Klauber-Demore N. Siamakpour-Reihani S, et al. Among authors: hilliard e. PLoS One. 2011;6(6):e20412. doi: 10.1371/journal.pone.0020412. Epub 2011 Jun 3. PLoS One. 2011. PMID: 21673995 Free PMC article.
A novel monoclonal antibody to secreted frizzled-related protein 2 inhibits tumor growth.
Fontenot E, Rossi E, Mumper R, Snyder S, Siamakpour-Reihani S, Ma P, Hilliard E, Bone B, Ketelsen D, Santos C, Patterson C, Klauber-DeMore N. Fontenot E, et al. Among authors: hilliard e. Mol Cancer Ther. 2013 May;12(5):685-95. doi: 10.1158/1535-7163.MCT-12-1066. Epub 2013 Apr 19. Mol Cancer Ther. 2013. PMID: 23604067 Free PMC article.
Development of a Novel Humanized Monoclonal Antibody to Secreted Frizzled-Related Protein-2 That Inhibits Triple-Negative Breast Cancer and Angiosarcoma Growth In Vivo.
Garcia D, Nasarre P, Bonilla IV, Hilliard E, Peterson YK, Spruill L, Broome AM, Hill EG, Yustein JT, Mehrotra S, Klauber-DeMore N. Garcia D, et al. Among authors: hilliard e. Ann Surg Oncol. 2019 Dec;26(13):4782-4790. doi: 10.1245/s10434-019-07800-2. Epub 2019 Sep 12. Ann Surg Oncol. 2019. PMID: 31515721 Free PMC article.
Overcoming PD-1 Inhibitor Resistance with a Monoclonal Antibody to Secreted Frizzled-Related Protein 2 in Metastatic Osteosarcoma.
Nasarre P, Garcia DI, Siegel JB, Bonilla IV, Mukherjee R, Hilliard E, Chakraborty P, Nasarre C, Yustein JT, Lang M, Jaffa AA, Mehrotra S, Klauber-DeMore N. Nasarre P, et al. Among authors: hilliard e. Cancers (Basel). 2021 May 30;13(11):2696. doi: 10.3390/cancers13112696. Cancers (Basel). 2021. PMID: 34070758 Free PMC article.
The anti-proliferative effects of a frankincense extract in a window of opportunity phase ia clinical trial for patients with breast cancer.
Valente IVB, Garcia D, Abbott A, Spruill L, Siegel J, Forcucci J, Hanna G, Mukherjee R, Hamann M, Hilliard E, Lockett M, Cole DJ, Klauber-DeMore N. Valente IVB, et al. Among authors: hilliard e. Breast Cancer Res Treat. 2024 Apr;204(3):521-530. doi: 10.1007/s10549-023-07215-4. Epub 2024 Jan 9. Breast Cancer Res Treat. 2024. PMID: 38194131 Free PMC article. Clinical Trial.
32 results